Kiyoshi Okazuka

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A Survey Study of Patient-Physician Communication and Treatment Decision-Making Preference at Treatment Initiation and After Disease Stabilization in Newly Diagnosed Multiple Myeloma.

A Survey Study of Patient-Physician Communication and Treatment Decision-Making Preference at Treatment Initiation and After Disease Stabilization in Newly Diagnosed Multiple Myeloma.

Journal: EJHaem

Published: October 03, 2025

Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients.

Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 01, 2025

A Multicenter Real-World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30-Positive Adult T-Cell Leukemia-Lymphoma.

A Multicenter Real-World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30-Positive Adult T-Cell Leukemia-Lymphoma.

Journal: Hematological oncology

Published: March 14, 2025

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

Journal: ESMO open

Published: March 01, 2025

Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in Japan.

Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in Japan.

Journal: Future oncology (London, England)

Published: November 04, 2022

Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.

Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.

Journal: Annals of hematology

Published: February 10, 2021

Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study

Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 10, 2020

Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation

Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 07, 2020

Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients

Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 07, 2019

The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.

The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.

Journal: European journal of haematology

Published: August 29, 2019

Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.

Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.

Journal: International journal of hematology

Published: June 04, 2019

Efficacy of plerixafor in autologous peripheral blood stem cell collection

Efficacy of plerixafor in autologous peripheral blood stem cell collection

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 10, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026